An open-label, multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in adult patients with newly diagnosed Fms-like tyrosine kinase receptor (FLT3) mutated Acute Myeloid Leukemia (AML) who are eligible for standard induction and consolidat

  • Markowitz, Avi (PI)

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date3/22/166/30/18

    Funding

    • Novartis Pharmaceuticals Corporation: $8,000.00